Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 63868-480-24), b.) 50-count bottles (NDC 63868-480-50) (CDMA)
Recalled November 13, 2019 · FDA recall D-0184-2020 · Dr. Reddy's Laboratories
Hazard
CGMP Deviations: Presence of NDMA impurity detected in product. · FDA Class II
Units
N/A
Sold at
Product was distributed to major distributors throughout the United States who may have further distributed the product.
Description
CGMP Deviations: Presence of NDMA impurity detected in product.
Product
Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 63868-480-24), b.) 50-count bottles (NDC 63868-480-50) (CDMA) OTC
Manufacturer(s)
Dr. Reddy's Laboratories, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →